Changes in Mass Treatment of the Canine Parvovirus ICU Population in Relation to Public Policy Changes during the COVID-19 Pandemic

Viruses. 2020 Dec 10;12(12):1419. doi: 10.3390/v12121419.

Abstract

Previous work has indicated that canine parvovirus (CPV) prevalence in the Central Texas region may follow yearly, periodic patterns. The peak in CPV infection rates occurs during the summer months of May and June, marking a distinct "CPV season". We hypothesized that human activity contributes to these seasonal changes in CPV infections. The COVID-19 pandemic resulted in drastic changes in human behavior which happened to synchronize with the CPV season in Central Texas, providing a unique opportunity with which to assess whether these society-level behavioral changes result in appreciable changes in CPV patient populations in the largest CPV treatment facility in Texas. In this work, we examine the population of CPV-infected patients at a large, dedicated CPV treatment clinic in Texas (having treated more than 5000 CPV-positive dogs in the last decade) and demonstrate that societal-behavioral changes due to COVID-19 were associated with a drastic reduction in CPV infections. This reduction occurred precisely when CPV season would typically begin, during the period immediately following state-wide "reopening" of business and facilities, resulting in a change in the typical CPV season when compared with previous years. These results provide evidence that changes in human activity may, in some way, contribute to changes in rates of CPV infection in the Central Texas region.

Keywords: COVID-19; canine; canine parvovirus; veterinary epidemiology.

MeSH terms

  • Animals
  • COVID-19 / epidemiology*
  • COVID-19 / prevention & control
  • Communicable Disease Control / legislation & jurisprudence
  • Dog Diseases / epidemiology*
  • Dog Diseases / therapy
  • Dogs
  • Hospitals, Animal
  • Humans
  • Intensive Care Units
  • Parvoviridae Infections / epidemiology
  • Parvoviridae Infections / therapy
  • Parvoviridae Infections / veterinary*
  • Parvovirus, Canine / pathogenicity
  • Prevalence
  • Public Policy
  • SARS-CoV-2
  • Texas / epidemiology